发明名称 Establishment of patient- or person-specific cardiac myocyte cell lines from human induced pluripotent stem cells (iPSCs)
摘要 A composition and method for generating patient- or person-specific proliferative and substantially pure cardiac myocyte cell lines from pluripotent stem cells (iPSCs) is described herein. The patient-specific cardiac myocyte cell lines of the present invention find applications in research, drug screening and autologous cell-based therapy. The method of the present invention is simple and reproducible and generates cardiac myocyte cells having high purities and proliferating capacities.
申请公布号 US9155765(B2) 申请公布日期 2015.10.13
申请号 US201213535964 申请日期 2012.06.28
申请人 Baylor Research Institute 发明人 Meng Xingli;Schiffmann Raphael;Shen Jinsong
分类号 A61P9/10;A61P7/04;C12Q1/68;A61P25/00;C12N5/077;C12Q1/02;G01N33/566;A61K35/34;C12N15/87;A61P9/00;G01N33/50;G01N33/68 主分类号 A61P9/10
代理机构 Norton Rose Fulbright US LLP 代理人 Norton Rose Fulbright US LLP
主权项 1. A method of obtaining a cardiac cell line from one or more induced pluripotent stem cells (iPSCs) comprising the steps of: a) culturing iPSCs in culture to form embryoid bodies; b) culturing the embryoid bodies so that they undergo further differentiation into beating and non-beating cardiac cell clusters; c) mechanically separating the beating cell clusters from the non-beating cells; d) culturing the non-beating cells from step c) under conditions wherein some of the cells form into beating cell clusters and some remain non-beating cells; e) mechanically separating the non-beating cells from the beating cell clusters formed in step d); and f) culturing and expanding the non-beating cells from step e) to form a cardiac cell line.
地址 Dallas TX US